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Infection of Mda5–/– and Tlr3–/– mice with EMCV-D causes different 



























TLR3 and MDA5 have nonredundant roles in the control of EMCV-D 
infection of pancreatic islets. It was previously shown that EMCV-D 































Both MDA5 and TLR3 protect from EMCV-D infection. WT, Mda5–/–, 
Tlr3–/–, and DKO mice were infected with 103 PFU of EMCV-D i.p. and 
monitored for survival (n = 20) in 2 independent experiments. WT mice 
survived infection, Mda5–/– mice succumbed on day 5, Tlr3–/– suc-
cumbed on day 22 with 30% surviving infection, and DKO mice suc-
cumbed on day 2.
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MDA5 controls EMCV-D infection in the heart. WT and KO mice were infected with 103 PFU of EMCV-D. Serum and heart (n ≥ 6 per time point, 
3 independent experiments) were harvested at days 2, 4, and 7 from surviving mice and were evaluated for (A) troponin levels by ELISA and 
(B) virus titer by plaque assay or fixed in formalin and paraffin embedded for histology. Tissue sections were stained for EMCVpol antigen by 
immunohistochemistry (C) (left column: original magnification, ×100 magnification; scale bars: 200 microns; right column: original magnification, 
×400; scale bars: 50 micron) or stained by H&E and evaluated for pathology (D) (original magnification, ×100; scale bar: 200 micron). In C, strong 
and diffuse EMCVpol reactivity is particularly evident in the myocardium of Mda5–/– and DKO; in contrast, heart from WT and Tlr3–/– animals 
showed only mild (WT) or focal (Tlr3–/–) staining, which is shown in detail in the right panel. In D, areas of myocarditis are observed in WT and 
Tlr3–/– on day 7 PI as well as in Mda5–/– day 4 PI; only mild inflammation is observed in Tlr3–/– day 4 PI. Statistical significance was calculated by 
2-tailed Student’s t test and is indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001.
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The IFN-I responses to EMCV-D induced by MDA5 and TLR3 are 










TLR3 and MDA5 protect pancreatic islets from EMCV-D infection. WT 
and KO mice were infected with 103 PFU EMCV-D. Serum samples 
were evaluated for (A) blood glucose (n ≥ 8) or (B) amylase and lipase 
(n ≥ 4) at the indicated times after infection in 2 independent experi-
ments. The pancreas was harvested at the indicated times and viral 
titers were determined by plaque assay (C) (n = 6 per time point, 3 
independent experiments) or fixed in formalin and paraffin embedded 
for histology. Tissue sections were stained using anti-EMCVpol (D) 
by immunohistochemistry (n > 3) to visualize virus infiltration (original 
magnification, ×100; scale bars: 200 micron) or by H&E and evaluated 
for pathology (E) (original magnification, ×200; scale bars: 100 micron). 
To further examine the role of MDA5 for protection in the pancreas, 
Mda5+/– animals on the C57BL/6 background were infected with 
EMCV-D in parallel with WT and Mda5–/– animals and were evaluated 
for blood glucose (F) and pancreatic viral titers (G) (n = 5). In addi-
tion, Mda5–/– animals on the 129/SvJ background were evaluated for 
hyperglycemia (H) (n = 12) after infection with EMCV-D. Statistical 
significance was calculated by 2-tailed Student’s t test and is indicated 
as follows: *P < 0.05; **P < 0.01; ***P < 0.001.
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Stromal MDA5 and hematopoietic cell TLR3 protect against EMCV-D infection. (A and B) BM chimeras were generated between WT and Mda5–/– 
(n = 10 each) and WT and Tlr3–/– animals (n = 12 each) in 2 independent experiments. Chimeras were infected with 103 PFU of EMCV-D and 
evaluated for (A) survival and (B) blood glucose. Mda5–/–→WT and WT→Tlr3–/– chimeras survived infection, WT→Mda5–/– chimeras succumbed 
on day 6, and Tlr3–/–→WT chimeras succumbed on day 14 with 67% surviving infection. (C) MDA5 expression in the pancreas (original magnifica-
tion, ×200; scale bars: 100 micron). Fixed tissue sections were made from Mda5–/– and WT pancreas on days 0, 2, and 4 after EMCV infection 
and stained with anti-MDA5 (n = 3). MDA5 is expressed in islets before infection and induced in both islets and exocrine pancreas after infection. 
(D) TLR3 expression in the pancreas. Frozen tissue sections were made from WT and Tlr3–/– pancreas from uninfected animals (first, second, 
and fourth panels) or from WT pancreas 12 hours after EMCV infection (third panel). Sections were stained with anti-TLR3 (brown) or costained 
with anti-TLR3 (brown) and synaptophysin (blue) to visualize expression in the islets (third panel) and are shown at different magnifications as 
indicated (original magnification, ×200, scale bars: 100 micron; original magnification, ×400, scale bars: 50 micron; original magnification, ×600, 
scale bars: 33 micron) (n = 3). TLR3 expression is found in the islets as well as in duct epithelial cells, vascular endothelial cells and interstitial 
stromal cells (arrowheads indicate TLR3+ interstitial cells).
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CD11c+ DC control EMCV-D infection and development of diabetes. (A) Identification of CD11c+ DCs in the islets. Serial frozen sections were 
made from the pancreas of uninfected WT animals and stained with anti-CD11c (left panel) and anti-TLR3 (right panel) (original magnification, 
×400; scale bar 50 micron) (n = 3). Arrowheads indicate CD11c+ cells that are also TLR3+. (B–E) CD11c+ DC are required for protection from 
EMCV-D–induced diabetes. CD11c-DTR mice were treated with PBS (n = 8) or DT (n = 8), then monitored for (B) blood glucose, (C) survival, 
(D) organ viral titers in the pancreas, heart, and spleen, and (E) serum IFN-I after EMCV-D infection. (F) Frozen sections were prepared from 
WT and CD11c-DTR PBS and DT-treated mice 48 hours after treatment. Immunohistochemical analysis of CD11c+ cells in the pancreas and 
spleens of these animals revealed depletion primarily in the spleen after DT treatment (original magnification, ×200; scale bars: 100 micron) 
(n = 3). Arrowheads indicate CD11c+ cells in the pancreas. (G) Frozen sections of spleens from WT and Tlr3–/– mice were used to perform 
immunohistochemical evaluation of TLR3 expression in the marginal and periarteriolar zones of the spleen (original magnification, ×200, scale 
bars: 100 micron) (n = 3). Statistical significance was calculated by 2-tailed Student’s t test and is indicated as follows: *P < 0.05; **P < 0.01.
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MDA5 and TLR3 induce type I IFN 
responses that are distinct in timing and 
magnitude. (A) Serum samples from 
WT, Mda5–/–, Tlr3–/–, and DKO mice were 
harvested at specified time points after 
EMCV-D infection and evaluated for type 
I IFN production by bioassay (n = 6 sam-
ples per time point performed in duplicate; 
results from 3 independent experiments). 
Irf3–/– (n = 8; 2 independent experiments) 
and Ifnb–/– (n = 6) mice were infected with 
EMCV-D and monitored for (B) blood glu-
cose levels and (C) survival. BM chimeras 
with Irf3–/– or Ifnb–/– BM into WT hosts (n = 6 
for each) were infected with EMCV-D and 
monitored for (D) blood glucose and (E) 
survival. Statistical significance was cal-
culated by 2-tailed Student’s t test and is 
indicated as follows: *P < 0.05; **P < 0.01; 
***P < 0.001.
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Mice and infections. Mda5–/–  and Mda5+/–  (48), Tlr3–/–  (51), DKO  (51), 
CD11c-DTR (58), Irf3–/– (59), and Ifnb–/– (60) mice have been described 
previously. All mice were backcrossed to the C57BL/6 background as 











































EMCV-D–induced diabetes in Tlr3–/– mice is 
characterized by islet infection, apoptosis, and 
myeloid cell infiltrate. Pancreas tissue samples 
from WT or Tlr3–/– mice were harvested at days 
0, 2, 4, or 7 PI as indicated, fixed in formalin, 
and paraffin embedded. (A) Sections were 
costained with anti-EMCVpol (brown) and anti-
synaptophysin (red) (top left panel); active cas-
pase-3 (brown) and anti-synaptophysin (blue) 
(top right panel); anti–Iba-1 (brown) and anti-
synaptophysin (blue) with H&E-stained insert 
(bottom left panel); or anti-EMCVpol (brown) 
and anti–Iba-1 (red) (bottom right panel) (left 
panels: original magnification, ×200, scale bars: 
100 micron, right panels: original magnification, 
×400, scale bars: 50 micron). By morphology, 
Iba-1+ cells correspond to large cells with irreg-
ular nuclei resembling macrophages (A, bottom 
left panel insert). As demonstrated by double 
immunohistochemistry, these islets contain 
numerous apoptotic cells and Iba1+ cells that 
react with antibodies against EMCVpol. (B) To 
visualize myeloid cell infiltrates, sections from 
WT and Tlr3–/– pancreas were stained with anti–
Iba-1 (original magnification, ×200; scale bars: 
100 micron). In WT pancreas, Iba-1+ cells are 
found at the periphery of the islets, whereas In 
Tlr3–/–, Iba-1+ cells infiltrate the islet.
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